Kaech C, Elzi L, Sendi P, Frei R, Laifer G, Bassetti S, Fluckiger U
Department of Internal Medicine, University Hospital Basel, Basel, Switzerland.
Clin Microbiol Infect. 2006 Apr;12(4):345-52. doi: 10.1111/j.1469-0691.2005.01359.x.
Staphylococcus aureus bacteraemia (SAB) is associated with substantial morbidity and mortality worldwide. The charts of adult patients with SAB who were hospitalised in a Swiss tertiary-care centre between 1998 and 2002 were studied retrospectively. In total, 308 episodes of SAB were included: 2% were caused by methicillin-resistant strains; 49% were community-acquired; and 51% were nosocomial. Bacteraemia without focus was the most common type of community-acquired SAB (52%), whereas intravenous catheter-related infection predominated (61%) among nosocomial episodes of SAB. An infectious diseases (ID) specialist was consulted in 82% of all cases; 83% received appropriate antibiotic treatment within 24 h of obtaining blood cultures. Overall hospital-associated mortality was 20%. Community-acquired SAB was associated independently with a higher mortality rate than nosocomial SAB (26% vs. 13%; p 0.009). Independent risk-factors for a fatal outcome were age (p < 0.001), immunosuppression (p 0.007), alcoholism (p < 0.001), haemodialysis (p 0.03), acute renal failure (p < 0.001) and septic shock (p < 0.001). Consultation with an ID specialist was associated with a better outcome in univariate analysis (p < 0.001). Compared with a previous retrospective analysis performed at the same institution between 1980 and 1986, there was a 140% increase in community-acquired SAB, a 60% increase in catheter-related SAB, and a 14% reduction in mortality. In conclusion, mortality in patients with SAB remained high, despite effective antibiotic therapy. Patients with community-acquired SAB were twice as likely to die as patients with nosocomial SAB. Consultation with an ID specialist may reduce mortality in patients with SAB.
金黄色葡萄球菌菌血症(SAB)在全球范围内都与较高的发病率和死亡率相关。我们对1998年至2002年间在瑞士一家三级护理中心住院的成年SAB患者的病历进行了回顾性研究。总共纳入了308例SAB病例:2%由耐甲氧西林菌株引起;49%为社区获得性;51%为医院获得性。无感染灶的菌血症是社区获得性SAB最常见的类型(52%),而在医院获得性SAB病例中,静脉导管相关感染占主导(61%)。在所有病例中,82%咨询了感染病(ID)专科医生;83%在获得血培养结果后24小时内接受了适当的抗生素治疗。总体医院相关死亡率为20%。社区获得性SAB独立于医院获得性SAB与更高的死亡率相关(26%对13%;p<0.009)。死亡结局的独立危险因素包括年龄(p<0.001)、免疫抑制(p<0.007)、酗酒(p<0.001)、血液透析(p<0.03)、急性肾衰竭(p<0.001)和感染性休克(p<0.001)。在单因素分析中,咨询ID专科医生与更好的结局相关(p<0.001)。与该机构在1980年至1986年间进行的先前回顾性分析相比,社区获得性SAB增加了140%,导管相关SAB增加了60%,死亡率降低了14%。总之,尽管有有效的抗生素治疗,SAB患者的死亡率仍然很高。社区获得性SAB患者死亡的可能性是医院获得性SAB患者的两倍。咨询ID专科医生可能会降低SAB患者的死亡率。